Article
CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma
17 May 2021
Abstract excerpt
BACKGROUND: As a significant cause of malignancy mortality, gastric carcinoma (GC) has been well documented to be an often-fatal diagnosis. Despite the limitations of effective therapy, immunotherapy has emerged as a promising therapeutic approach capable of killing cancer cells via the immune system. The current study was conducted to investigate the effect of cytokine C-C motif chemokine ligand 21 (CCL21) on GC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
